Researchers discover how cancer 'invisibility cloak' works

October 28, 2013, National Jewish Health
Researchers discover how cancer 'invisibility cloak' works

Researchers at National Jewish Health have discovered how a lipid secreted by cancer tumors prevents the immune system from mounting an immune response against it. When lysophosphatidic acid (LPA) binds to killer T cells, it acts almost like an "invisibility cloak," preventing T cells from recognizing and attacking nascent tumors.

"In recent years, several therapeutic medicines have been developed that spur a person's own immune system to fight ," said Raul Torres, PhD, professor of immunology at National Jewish Health, and senior author on the paper, published in the October issue of Cancer Immunology Research. "Our findings suggest new targets and strategies for enlisting the immune system's help in fighting cancer."

Scientists believe the human immune system recognizes and destroys many cancerous before they develop into dangerous tumors. However, tumors also employ strategies to evade detection by the immune system.

Scientists have known that LPA is secreted by many types of cancer cells, appears to promote the growth and spread of cells, and that immune cells known as CD-8 "killer" T cells have several receptors for LPA. Killer T cells can destroy when activated against them.

In the new paper, researchers led by Dr. Torres showed that LPA keeps T cells inactivated even after they have "seen" a target, or antigen, on a cancer cell that would normally trigger an immune response. They identified the LPA5 receptor as the specific receptor responsible for inhibiting the immune response. In cell cultures and in mice LPA prevented signaling within cells, the appearance of molecules associated with T-cell activation, and proliferation of the T cells. When they transferred T cells lacking the LPA5 receptor into mice with cancer, tumor growth essentially halted.

"Knowing specifically how LPA inhibits the suggests several strategies for harnessing the immune system's natural ability to fight cancer," said Dr. Torres.

Explore further: Some immune cells appear to aid cancer cell growth, study finds

Related Stories

Some immune cells appear to aid cancer cell growth, study finds

September 5, 2013
The immune system is normally known for protecting the body from illness. But a subset of immune cells appear to be doing more harm than good.

Modulating the immune system to combat metastatic cancer

May 24, 2013
Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ...

Depletion of 'traitor' immune cells slows cancer growth in mice

September 16, 2013
When a person has cancer, some of the cells in his or her body have changed and are growing uncontrollably. Most cancer drugs try to treat the disease by killing those fast-growing cells, but another approach called immunotherapy ...

Study reveals that chemotherapy works in an unexpected way

April 4, 2013
It's generally thought that anticancer chemotherapies work like antibiotics do, by directly killing off what's harmful. But new research published online on April 4 in the Cell Press journal Immunity shows that effective ...

Study shows how Staph toxin disarms the immune system

October 16, 2013
Researchers at NYU Langone Medical Center have discovered a new mechanism by which the deadly Staphylococcus aureus bacteria attack and kill off immune cells. Their findings, published today in the journal Cell Host & Microbe, ...

Researchers discover how immune system kills healthy cells

September 10, 2013
Medical scientists at the University of Alberta have made a key discovery about how the immune system kills healthy cells while attacking infections. This finding could one day lead to better solutions for cancer and anti-viral ...

Recommended for you

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

New immunotherapy approach boosts body's ability to destroy cancer cells

January 12, 2018
Few cancer treatments are generating more excitement these days than immunotherapy—drugs based on the principle that the immune system can be harnessed to detect and kill cancer cells, much in the same way that it goes ...

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors

January 12, 2018
The field of immunotherapy - the harnessing of patients' own immune systems to fend off cancer - is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of ...

FDA approves first drug for tumors tied to breast cancer genes

January 12, 2018
(HealthDay)—The U.S. Food and Drug Administration on Friday approved the first drug aimed at treating metastatic breast cancers linked to the BRCA gene mutation.

Breast cancer gene does not boost risk of death: study

January 12, 2018
Young women with the BRCA gene mutation that prompted actress Angelina Jolie's pre-emptive and much-publicised double mastectomy are not more likely to die after a breast cancer diagnosis, scientists said Friday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.